Flynn James E 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 12:39 pm Sale | 2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Flynn James E | 457,500 2.730% | -449,437 (-49.56%) | Filing |